Skip to main content
Premium Trial:

Request an Annual Quote

Beijing Genomics Institute Signs First Volunteer for Project to Sequence 100 Human Genomes

NEW YORK (GenomeWeb News) - The Beijing Genomics Institute said today that it has signed the first volunteer in a project to sequence 100 human genomes.
The initiative, called the Yanhuang Project after two ancient emperors who are believed to be the ancestors of the Han ethnic group, will map the genomes of 100 people that it will use to construct a Chinese genetic polymorphism map.
Last fall, BGI researchers sequenced the first Chinese individual using Illumina’s Genome Analyzer. The anonymous volunteer for the Yanhuang Project would be the second human genome sequenced by the institute.
BGI did not disclose the amount the individual donated, but China’s Xinhua News Service reported this week that it was 10 million yuan ($1.3 million).
Last month, BGI announced that it has begun offering sequencing services using its fleet of more than 120 sequencers, which includes Applied Biosystems 3730xl sequencers, Amersham MegaBace sequencers, seven Illumina Genome Analyzers, and two ABI SOLiDs.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.